Status:
COMPLETED
Effect of the Antiandrogen DDE on Anthropometric Measures at Birth
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
DDT
Eligibility:
All Genders
Up to 35 years
Brief Summary
Experimental studies have documented the p'p-DDT, p'p-DDE (a metabolite of DDT) and other organochlorine (OC) compounds have estrogenic and/or antiandrogenic activities capable of altering normal endo...
Detailed Description
We propose to follow the women and children enrolled in our original study (n= approximately 850 of each). In the original study, women were enrolled and interviewed while in the hospital for delivery...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Pregnant women delivering male infants in Tapachula and surrounding areas.
- EXCLUSION CRITERIA:
- Women must not be over 35 years of age.
- A physician's diagnosis of multiple fetuses, pre-eclampsia or pregnancy-related hypertension disorders or psychiatric, kidney, or cardiac disease; gestational diabetes; history of repeated urinary infections; seizure disorder requiring daily medications; ingestion of corticosteroids, and non-Spanish speakers.
- At time of birth, additional exclusion criteria will include: an Apgar score (at five minutes) of 6 or less; any condition requiring treatment in the neonatal intensive care unit.
- Infants must not have any condition requiring treatment in the neonatal intensive care unit.
Exclusion
Key Trial Info
Start Date :
May 14 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
2118 Patients enrolled
Trial Details
Trial ID
NCT00343031
Start Date
May 14 2001
End Date
December 10 2019
Last Update
December 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute for Public Health
Cuernavaca, Mexico